Recently, S100A12 was reported to be significantly expressed in the plasma of patients with Blau syndrome (BS, a dominant hereditary autoinflammatory disease), the number of active joints was strongly linked with the amount of S100A12, and S100A12 was discovered to be a biomarker of joint disease activity in BS patients [33]. The gene discussed is S100A12; the disease is Blau syndrome.